Midatech Pharma PLC Announces R&D Programme Focused on Lepto

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 27, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines

Related Keywords

United Kingdom , United States , London , City Of , Matthew Chandler Rob Patrick , Midatech Pharma Plcview , Dmitry Zamoryakhin , Tim Metcalfe Graham , Edison Group Us Investor Relations , Strand Hanson Limited Nominated Adviser , London Stock Exchange , Midatech Pharma , Nasdaq , Advisory Limited Financial , Exchange Commission , Chemoresistant Ovarian , Intj Mol , Hanson Limited , Nominated Adviser , Matthew Chandler , United Kingdom Investor Relations , Transparency Rules , London Stock , Midatech , Dharma , Nnounces , Programme , Ocused , Leptomeningeal , Disease ,